Tec family kinases are implicated in T cell receptor (TCR) signaling, and combined mutation of inducible T cell kinase (Itk) and resting lymphocyte kinase (Rlk)/Txk in mice dramatically impairs mature T cell function. Nonetheless, mutation of these kinases still permits T cell development. While itk−/− mice exhibit mild reductions in T cells with decreased CD4/CD8 cell ratios, rlk−/−itk−/− mice have improved total T cell numbers yet maintain decreased CD4/CD8 ratios. Using TCR transgenics and an in vitro thymocyte deletion model, we demonstrate that mutation of Tec kinases causes graded defects in thymocyte selection, leading to a switch from negative to positive selection in rlk−/−itk−/− animals. The reduction in both positive and negative selection and decreased CD4/CD8 ratios correlates with decreased biochemical parameters of TCR signaling, specifically defects in capacitive Ca2+ influx and activation of the mitogen-activated kinases extracellular signal–regulated kinase 1 and 2. Thus, Tec kinases influence cell fate determination by modulating TCR signaling, leading to altered thresholds for thymocyte selection. These results provide support for a quantitative model for thymic development and provide evidence that defects in negative selection can substantially alter thymic cellularity.
Skip Nav Destination
Article navigation
2 October 2000
Article|
October 02 2000
Tec Family Kinases Modulate Thresholds for Thymocyte Development and Selection
Edward M. Schaeffer,
Edward M. Schaeffer
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
cDepartment of Pathology, University of Chicago, Chicago, Illinois 60637
Search for other works by this author on:
Christine Broussard,
Christine Broussard
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Search for other works by this author on:
Jayanta Debnath,
Jayanta Debnath
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Search for other works by this author on:
Stacie Anderson,
Stacie Anderson
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Search for other works by this author on:
Daniel W. McVicar,
Daniel W. McVicar
bNational Cancer Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Search for other works by this author on:
Pamela L. Schwartzberg
Pamela L. Schwartzberg
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Search for other works by this author on:
Edward M. Schaeffer
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
cDepartment of Pathology, University of Chicago, Chicago, Illinois 60637
Christine Broussard
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Jayanta Debnath
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Stacie Anderson
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Daniel W. McVicar
bNational Cancer Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Pamela L. Schwartzberg
aNational Human Genome Research Institute, Frederick Cancer Research and Development Center, National Institutes of Health, Frederick, Maryland 21702
Abbreviations used in this paper: DP, double-positive; ERK, extracellular signal–regulated kinase; GRB, growth factor receptor–bound protein; HSA, human serum albumin; LAT, linker of activated T cells; MAP, mitogen-activated protein; PI, propidium iodide; PLC, phospholipase C; SP, single-positive; WT, wild-type; XLA, X-linked agammaglobulinemia.
Received:
May 16 2000
Revision Requested:
July 19 2000
Accepted:
August 09 2000
Online ISSN: 1540-9538
Print ISSN: 0022-1007
© 2000 The Rockefeller University Press
2000
The Rockefeller University Press
J Exp Med (2000) 192 (7): 987–1000.
Article history
Received:
May 16 2000
Revision Requested:
July 19 2000
Accepted:
August 09 2000
Citation
Edward M. Schaeffer, Christine Broussard, Jayanta Debnath, Stacie Anderson, Daniel W. McVicar, Pamela L. Schwartzberg; Tec Family Kinases Modulate Thresholds for Thymocyte Development and Selection. J Exp Med 2 October 2000; 192 (7): 987–1000. doi: https://doi.org/10.1084/jem.192.7.987
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Sign in via your Institution
Sign in via your InstitutionSuggested Content
Email alerts
Advertisement